Nu-MedLogo.jpg
Nu-Med Plus Announces Filing of U.S. Provisional Patent Application for Nitric Oxide in Aqueous Solution for Wound Care Treatment
November 03, 2020 07:30 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical...
Nu-MedLogo.jpg
Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device
July 28, 2020 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
Nu-MedLogo.jpg
Patent Issuance Allowed for Single-Use or Short-Term Nitric Oxide Delivery Device
May 28, 2020 08:00 ET | Nu-Med Plus Inc.
´╗┐´╗┐SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
Nu-MedLogo.jpg
Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19
March 25, 2020 06:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical...
Nu-MedLogo.jpg
Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage
January 07, 2020 06:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), National Investment Bankers Association (NIBA) presenter Nu-Med Plus, Inc., a medical device development company...
Nu-MedLogo.jpg
Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City
December 03, 2019 05:30 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), announced today that the Company attended and presented at the 147th National Investment Banking Association (NIBA)...
Nu-MedLogo.jpg
Nu-Med Plus, Inc. Fast-Tracked Development Plan for Nitric Oxide Delivery Device Gaining Momentum
October 23, 2019 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-MedLogo.jpg
Nu-Med Plus Accelerates FDA Submission in Light of Patent Ruling
September 10, 2019 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device developer of new nitric oxide delivery technology announced that it will be accelerating the FDA...
Nu-MedLogo.jpg
Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
June 18, 2019 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-MedLogo.jpg
Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners
April 03, 2019 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, reports an increase in strategic...